vimarsana.com

Page 8 - பார்க்லேஸ் உலகளாவிய சுகாதாரம் மாநாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kindred Biosciences to Present at Barclays Global Healthcare Conference and H C Wainwright Global Life Sciences Conference

An archived version of the above webcasts will be available for 30 days on the KindredBio website. About Kindred Biosciences  Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company s strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio.

eHealth, Inc to Present at Barclays Global Healthcare Conference

Share this article SANTA CLARA, Calif., March 1, 2021 /PRNewswire/  eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance marketplace, today announced that its management will present at the  Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 11:30 a.m. E.T.  Interested investors can access the live audio webcast of eHealth s presentation at www.ehealthinsurance.com under Investor Relations. Please visit the website at least 15 minutes early to register, download, and install any necessary software. A replay of this event will be available on the company s website shortly after the conclusion of the event and will remain available for 14 days.

LogicBio Therapeutics to Present at Upcoming Investor Conferences

LogicBio Therapeutics to Present at Upcoming Investor Conferences News provided by Share this article Share this article LEXINGTON, Mass., Feb. 26, 2021 /PRNewswire/  LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today announced that chief executive officer Frederic Chereau will be presenting an overview of the company at upcoming investor conferences. Mr. Chereau will present at the Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 4:10 p.m. ET. A link to the Barclays presentation will be available under the Events and Presentations section of LogicBio s website, found here: https://investor.logicbio.com/events-and-presentations/events.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.